{"version":"1.0","type":"link","title":"AL2846, a novel multi-kinase inhibitor, for previously treated radioiodine-refractory differentiated thyroid cancer: Exploratory clinical results from the phase Ib study.","author_name":"Shi F 외","author_url":"https://prs-insight.online/author/Shi%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/138976","thumbnail_width":1200,"thumbnail_height":630}